Latest return on equity
Aclaris Therapeutics Return on equity
Direct answer
Aclaris Therapeutics's return on equity is -59.1%.
The verified market snapshot reports -59.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 6, 2026.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -59.1%
Explore related company data
View Aclaris Therapeutics's market capitalizationView Aclaris Therapeutics's price-to-book ratioView Aclaris Therapeutics's 52-week price rangeView Aclaris Therapeutics's revenue growthView Aclaris Therapeutics's profit marginView Aclaris Therapeutics's debt-to-equity ratioView all Aclaris Therapeutics key metricsReturn to Aclaris Therapeutics profile